Porta Clinica offers consulting across a range of clinical research and drug
development activities including study design and protocol writing,
pre-IND strategy, Medical Monitoring, serving as independent DSMB
member, collaborating in IND and other regulatory submissions, analyzing
study data. Previous broad-based experience as principal investigator in
early-phase and later phase clinical trials, certified physician investigator
(CPI). Emphasis on translational research, with particular interest areas in oncology,
hematology, infectious disease, and immunology.
